AngioDynamics announced the completion of patient enrollment in the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System, or APEX-AV. APEX-AV is a clinical study aimed at evaluating the safety and efficacy of the Company’s AlphaVac Multipurpose Mechanical Aspiration, or MMA, F1885 System in the treatment of acute intermediate-risk pulmonary embolism.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ANGO:
